Tokyo Olympian Shivpal Singh Faces Career-Ending 10-Year Doping Ban

NEW DELHI: The career of Indian javelin star and Tokyo Olympian Shivpal Singh has reached a likely premature conclusion after the National Anti-Doping Agency (NADA) Disciplinary Panel handed the athlete a 10-year suspension. The sanction, stemming from a second doping offense involving the banned anabolic steroid methandienone, marks a dramatic fall for the 31-year-old thrower.

Once a beacon of promise in Indian athletics, Shivpal secured his place on the international stage with a stellar performance at the 2019 Asian Championships in Doha, where he clinched a silver medal with a personal-best throw of 86.23 meters. However, his professional trajectory has been marred by repeated scrutiny from anti-doping authorities.

A History of Legal Battles

The current 10-year ban is the latest in a complex series of disciplinary actions. In August 2022, the NADA panel originally imposed a four-year ban on Shivpal following a positive test for a steroid during an out-of-competition screening in 2021.

Shivpal mounted a successful legal challenge, appealing to NADA’s panel with the argument that the failed test resulted from "contaminated supplements." In a surprising turn of events, the Appeal Panel accepted his defense in January 2023, slashing his suspension from four years to just one.

The reduced sentence allowed for a swift return to the field in April 2023. Shivpal appeared to capitalize on his second chance, securing a bronze medal at the National Inter-State Championships in Bhubaneswar and a gold at the National Games in Goa later that year. However, this resurgence has now been overshadowed by his second anti-doping rule violation, which triggered the significantly harsher decade-long penalty, effectively ending his competitive tenure.

Rising Doping Concerns in Indian Athletics

The case of the Olympian Shivpal Singh is not an isolated incident within the Indian sporting landscape. NADA has been aggressively pursuing multiple high-profile cases as part of a broader crackdown on performance-enhancing drugs.

Among those facing disciplinary action is former Asian Games heptathlon champion Swapna Barman, who has been provisionally suspended after testing positive for boldenone, an anabolic-androgenic steroid. Despite Barman announcing her retirement earlier this month, she remains subject to the full regulatory process. Sources indicate she is entitled to request a B-sample analysis and will be required to face a formal hearing.

The ongoing disciplinary wave also includes sprinter MV Jilna, who is currently under provisional suspension for a second offense involving mephentermine. Additionally, the NADA panel has issued a four-year ban to hockey player Mayank Sharma for an out-of-competition failure, and a five-year sanction to 19-year-old runner Sanjana Singh for the use of prohibited steroids.

As these cases continue to unfold, the Indian sporting community faces renewed questions regarding the prevalence of doping and the efficacy of current education and monitoring programs for elite athletes.